U.S. Entertainment Stock News

NasdaqGS:INTU
NasdaqGS:INTUSoftware

Intuit (INTU) Is Down 20.6% After AI Pivot, Layoffs And Higher Outlook - Has The Bull Case Changed?

In May 2026, Intuit reported higher third-quarter and year-to-date revenue and earnings, raised its full-year outlook, confirmed a US$1.20 quarterly dividend, and announced a 17% reduction of its full-time workforce that will trigger an estimated US$300 million to US$340 million in restructuring charges. The company simultaneously completed a multi-year share repurchase program totaling about US$12.57 billion and outlined further AI-focused product enhancements, highlighting an aggressive...
NYSE:ACHR
NYSE:ACHRAerospace & Defense

Archer Aviation (ACHR) Is Up 7.4% After Key FAA And UAE Certification Milestones - What's Changed

In the past few weeks, Archer Aviation reported first-quarter 2026 results showing US$1.6 million in sales alongside a wider net loss of US$217.7 million, while also advancing its Midnight eVTOL through Phase 3 of 4 in the FAA Type Certification process and entering the UAE’s Restricted Type Certificate program for limited Abu Dhabi operations. These regulatory milestones, combined with participation in Abu Dhabi’s emerging air taxi market and fresh institutional interest, have sharpened...
NYSE:KEX
NYSE:KEXShipping

Did Kirby’s EPS-Fueled Free Cash Flow Surge Just Shift Its (KEX) Investment Narrative?

In recent years, Kirby Corporation has reported 11.1% annual revenue growth, 24% annual earnings per share growth aided by share buybacks, and a significant improvement in free cash flow margin, all contributing to stronger financial flexibility by today’s date, 25 May 2026. An interesting aspect of this performance is that earnings per share have grown more than twice as fast as revenue, highlighting how Kirby’s capital returns and expanding free cash flow have magnified shareholder value...
NasdaqGS:DOX
NasdaqGS:DOXIT

Amdocs’ Unusual Charge, Guidance Shift And Executive Changes Might Change The Case For Investing In DOX

Amdocs recently reported second-quarter 2026 results showing sales of US$1,171.98 million and lower earnings due partly to an unusual US$100 million expense, while issuing updated guidance, confirming its quarterly dividend, detailing progress on its share repurchase program, and announcing upcoming CFO and COO retirements and appointments. Despite the short-term earnings impact, Amdocs highlighted resilient operations, ongoing customer wins in cloud and AI-led modernization, and scheduled...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Is Microsoft (MSFT) Now Attractive After Recent Share Price Weakness?

Wondering if Microsoft at US$418.57 is a bargain, fairly priced, or too expensive for your portfolio? This article breaks down what the current share price might be implying about the stock. The share price has eased recently, with returns declining 1.2% over the past week, 1.4% over the past month, and 11.5% year to date, even though the 3 year and 5 year returns stand at 28.7% and 74.7% respectively. Recent headlines around Microsoft continue to focus on its role in software and broader...
NasdaqGS:TTEK
NasdaqGS:TTEKCommercial Services

Tetra Tech (TTEK) Valuation Check After Recent Share Price Weakness And Undervalued Narrative

Recent share performance and business snapshot Tetra Tech (TTEK) has drawn fresh attention after a mixed period for the stock, with recent daily and weekly gains sitting against declines over the past month, past 3 months, year to date, and past year. At a last close of US$27.65 and a market value of about US$7.2b, the company sits in the consulting and engineering space, focused on water, environmental services, and sustainable infrastructure across government and commercial clients. See our...
NYSE:PEB
NYSE:PEBHotel and Resort REITs

How Analyst Confidence in Preferred Payouts Could Reframe Pebblebrook Hotel Trust’s (PEB) Risk Narrative

Recently, analysts highlighted Pebblebrook Hotel Trust’s Series G preferred shares, emphasizing their strong yield, sizable discount to liquidation value, and coverage metrics suggesting contained credit risk. A key takeaway from this commentary is the focus on robust funds from operations and a relatively low payout ratio, which together support confidence in Pebblebrook’s capacity to keep meeting preferred distributions. We’ll now examine how this confidence in preferred distribution...
NYSE:CRK
NYSE:CRKOil and Gas

Evaluating Comstock Resources (CRK) Valuation After Recent Share Price Weakness

Comstock Resources (CRK) is back on investors’ radar after recent trading pressure, with the stock down 18% over the past month and 24% over the past 3 months. This has prompted closer attention to its fundamentals. See our latest analysis for Comstock Resources. At the current share price of $13.94, Comstock Resources has seen its share price decline sharply over the year to date, while the 3 year and 5 year total shareholder returns remain positive. This indicates that recent momentum looks...
NYSE:O
NYSE:ORetail REITs

Realty Income Expands 2026 Investment Plan And Private Capital Platform

Realty Income (NYSE:O) raised its 2026 investment target to $9.5b, up from $8.0b. Alternatively, the company expanded its private capital efforts with a $1.0b joint venture and $1.7b raised for its U.S. Core Plus fund. These moves focus on real estate acquisitions, development-related investments, and structured credit deals. Realty Income, trading around $62.02, has delivered a return of 18.0% over the past year and 24.9% over the past three years. The company is known for its net lease...
NYSE:AGL
NYSE:AGLHealthcare

A Look At Agilon Health (AGL) Valuation After CEO Change And Strong Guidance Update

Why Tim O’Rourke’s Arrival and Fresh Guidance Matter for agilon health Stock The recent appointment of Tim O’Rourke as CEO of agilon health (AGL), alongside better-than-expected first-quarter results and higher full-year sales guidance, puts fresh attention on how this value-based care company is repositioning its business. See our latest analysis for agilon health. agilon health’s 1 day share price return of 7.22% came after the CEO announcement and guidance update, capping a very large 90...
NYSE:APH
NYSE:APHElectronic

Why Amphenol (APH) Is Up 8.5% After New AI Data Center Optics Alliance Agreement

In May 2026, 3M announced that it and a group of technology and infrastructure leaders, including Amphenol, formed a new multi-source agreement to develop open, interoperable expanded beam optical connector specifications for AI data centers, aiming to simplify deployment and improve reliability in high-density environments. This alliance underscores Amphenol’s role in shaping emerging fiber optic standards for AI infrastructure, aligning its connector portfolio with the technical...
NYSE:PVH
NYSE:PVHLuxury

PVH (PVH) Valuation Check As New Leadership Team Takes Shape

PVH (PVH) is back in focus after a broad refresh of its leadership team, including Adelyn Cheong’s promotion to CEO of PVH Americas and new appointments across licensing and consumer strategy. See our latest analysis for PVH. The leadership reshuffle lands as PVH’s share price trades at $88.92, with a 1-day share price return of 2.55% and 7-day share price return of 10.69%. This contrasts with a 30-day share price return that is down 5.04%, while the 90-day share price return of 28.78% and...
NYSE:IBM
NYSE:IBMIT

IBM’s US$1b Quantum Foundry Bet Reshapes Long Term Investor Story

IBM (NYSE:IBM) is receiving a US$1b investment from the U.S. Department of Commerce to create Anderon, a new quantum chip foundry subsidiary. IBM will match the government funding and contribute intellectual property and talent to build the nation's first pure-play quantum chip foundry. Anderon is intended to serve multiple quantum vendors and clients, positioning IBM at the center of the emerging U.S. quantum hardware ecosystem. For investors watching NYSE:IBM, this move extends the...
NasdaqGS:PENG
NasdaqGS:PENGSemiconductor

Assessing Penguin Solutions (PENG) Valuation After Board Appointment And AI Infrastructure Focus

Penguin Solutions (PENG) is back on radar after appointing Nokia executive David Heard to its board, a move directly tied to the company’s push into AI infrastructure and advanced memory technologies. See our latest analysis for Penguin Solutions. The board appointment and sector-wide enthusiasm around AI infrastructure have arrived during a strong run, with a 30-day share price return of 73.38% and a 1-year total shareholder return of 201.64%. This suggests momentum has been building rather...
NYSE:UAMY
NYSE:UAMYMetals and Mining

A Look At United States Antimony’s Valuation After Its First Quarter 2026 Earnings Setback

Why United States Antimony’s Latest Earnings Are Drawing Attention United States Antimony (UAMY) reported first quarter 2026 results that showed sales of US$6.78 million compared with US$7 million a year earlier, alongside a shift from net income to a net loss of US$11.29 million. See our latest analysis for United States Antimony. The earnings setback comes after a sharp run in the stock, with a year to date share price return of 41.99% and a 1 year total shareholder return above 200%...
NasdaqGS:CEVA
NasdaqGS:CEVASemiconductor

Is CEVA’s (CEVA) New Bluetooth Win Quietly Rewriting Its Edge Connectivity Story?

CEVA, Inc. recently reported first-quarter 2026 results showing revenue of US$27.02 million versus US$24.25 million a year earlier, alongside a net loss of US$4.46 million and a new major customer win for its integrated Bluetooth High Data Throughput solution incorporating internally developed RF technology. This combination of higher revenue and a move toward more integrated wireless platforms suggests CEVA is deepening its role within customers’ connectivity roadmaps across multiple...
NYSE:GAP
NYSE:GAPSpecialty Retail

A Look At Gap (GAP) Valuation After Banana Republic Leadership Change

Gap (GAP) is back on investor radars after the stock jumped 6.6% following the appointment of Donald Kohler as President and CEO of Banana Republic, effective July 2026. See our latest analysis for Gap. That 6.6% jump sits against a mixed backdrop, with the share price up 12.8% over the past week but down 6.4% over 30 days and 7.2% year to date. The 3 year total shareholder return of roughly 3x signals longer term momentum that has previously been strong. If this kind of leadership driven...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

Sharplink (SBET) Valuation In Focus After Galaxy Onchain Yield Fund Memorandum Of Understanding

Event overview and why it matters for Sharplink stock Sharplink (NasdaqCM:SBET) just entered a non binding memorandum of understanding with Galaxy Digital to create the Galaxy Sharplink Onchain Yield Fund, LP, a private vehicle focused on onchain yield strategies. The planned fund would start with US$125 million, including US$100 million from Sharplink's staked Ethereum treasury and US$25 million from Galaxy. It is intended to put Sharplink's existing digital assets to more active use. See...
NasdaqGS:AMKR
NasdaqGS:AMKRSemiconductor

The Bull Case For Amkor Technology (AMKR) Could Change Following Arizona Expansion And 2028 Targets - Learn Why

In May 2026, Amkor Technology, Inc. expanded its Arizona advanced semiconductor packaging and test campus by securing an additional 67-acre parcel and reaffirmed its capital-return framework with a quarterly cash dividend of US$0.08352 per share. At its 2026 Investor Day, the company detailed an Arizona build-out central to its long-term growth plan while issuing 2028 financial targets that lagged market expectations and coincided with recent insider share sales. Next, we will examine how...
NasdaqGS:SVRA
NasdaqGS:SVRABiotechs

New aPAP Phase 3 Data and Wider Losses Might Change The Case For Investing In Savara (SVRA)

Earlier in May, Savara Inc. reported new Phase 3 IMPALA-2 data at the ATS 2026 meeting showing that nebulized molgramostim improved exercise capacity and related measures in adults with autoimmune pulmonary alveolar proteinosis, while also posting a wider quarterly net loss of US$37.28 million. The convergence of clinically meaningful functional gains in a rare lung disease and preparations ahead of an FDA Priority Review has sharpened attention on molgramostim’s potential role in the aPAP...
NasdaqGS:NTCT
NasdaqGS:NTCTCommunications

Do NetScout Systems' (NTCT) Earnings Beats Hint at a Deeper Shift in Its Investment Narrative?

In recent months, NetScout Systems reported earnings that exceeded analyst expectations, reinforcing confidence in its operations and prompting analysts to revise earnings estimates higher. This pattern of positive surprises and upward estimate revisions has strengthened the perception that NetScout’s current execution may be better aligned with analyst expectations than previously assumed. With these earnings beats and higher forecasts in mind, we’ll now examine how this shift in...
NasdaqGS:VSAT
NasdaqGS:VSATCommunications

Assessing Viasat (VSAT) Valuation After New US$437.7m Defense Contract With Intelsat

Viasat (VSAT) is back in focus after securing a US$437.7 million government contract with Intelsat General Communications for the Protected Tactical Satellite Global program, a move that highlights its defense communications capabilities. See our latest analysis for Viasat. The contract win comes on top of a strong run in the stock, with a 30-day share price return of 20.28% and a 90-day gain of 55.59%, while the 1-year total shareholder return of around 7x suggests momentum has been building...
NYSE:INSP
NYSE:INSPMedical Equipment

A Look At Inspire Medical Systems (INSP) Valuation As Analyst Caution Rises On Reimbursement Coding Risks

Recent analyst commentary on Inspire Medical Systems (INSP) has turned more cautious, highlighting reimbursement coding challenges and the need for clearer catalysts. This shift has brought renewed attention to the stock’s risk profile. See our latest analysis for Inspire Medical Systems. The recent caution from analysts comes after a period where the stock’s 30 day share price return is down 22.15% and the year to date share price return is down 52.49%, while the 1 year total shareholder...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Is It Too Late To Consider Nasdaq (NDAQ) After A 75% Three Year Gain?

If you are wondering whether Nasdaq at around US$91 a share is still a solid entry or more fully priced, this article walks you through what the current valuation suggests. The stock is down 1.7% over the past week and down 5.8% year to date, but it is up 12.6% over the past year and 75.1% over three years, which can signal shifting views on both its growth potential and risk. Recent coverage has focused on Nasdaq's role as a major market operator and its position in capital markets...